FABP4 and metabolic dysfunction-associated steatohepatitis: The FABP4 inhibitor BMS309403 treats mice with acute liver injury and non-alcoholic steatohepatitis by inhibiting proinflammatory responses in isolated rat Kupffer cells [30].